Clarity on Covid Count: Pandemic’s Toll on Seniors Extended Well Beyond Nursing Homes
(By Judith Graham for Kaiser Health News) As covid-19 resurges across the country, driven by the highly infectious delta variant,
Read More
Alzheimer’s/Dementia
New scanning technology could help diagnose Alzheimer’s disease using light
(Source – www.blogs.va.gov) Researchers with the VA Bedford and VA Boston health care systems have developed a non-invasive optical technique
Read MoreAlzheimer’s patients are in limbo as hospitals, insurers grapple with whether to offer Aduhelm
(By Andrew Joseph and Rachel Cohrs for STAT) For all the explosive controversy over the approval of the first treatment
Read MoreA New Alzheimer’s Drug Comes With Lots Of Questions About How To Use It
(By Jon Hamilton for NPR) Nearly two months after the Alzheimer’s drug Aduhelm received conditional approval from the Food and Drug
Read MoreFacing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign
(By Julie Appleby for Kaiser Health News) Do you sometimes lose your train of thought or feel a bit more
Read MoreUnitedHealth CEO: Unknowns of Biogen Alzheimer’s drug mean insurer won’t yet cover it
(By Nick Moran for Becker’s Hospital Review) UnitedHealth Group CEO Andrew Witty said the payer needs to see more data on
Read MoreHow Might the FDA’s Approval of a New Alzheimer’s Drug Impact Medicaid?
(By Rachel Dolan and Elizabeth Williams for Kaiser Family Foundation published July 13, 2021) The recent approval of Aduhelm (aducanumab),
Read MoreCMS pushed to set national policy on Aduhelm access
(By Nick Moran for Becker’s Hospital Review) The Alzheimer’s Association joins insurers as the latest to call for CMS to
Read MoreWhy We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
(By Elisabeth Rosenthal for Kaiser Health News) The Food and Drug Administration’s approval in June of a drug purporting to
Read MoreDoctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug
(By Judith Graham for Kaiser Health News) As physicians and health policy experts debate the merits of Aduhelm, the first
Read More